Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen.
作者信息
Peters Christina, Bruno Angela, Rizzari Carmelo, Brescianini Alessandra, Von Stackelberg Arend, Linderkamp Christin, Zeng Yi, Zugmaier Gerhard, Locatelli Franco
机构信息
St. Anna Children's Hospital, St. Anna Children's Cancer Research Institute, University Vienna, Vienna.
Amgen Italia, Milan.
出版信息
Haematologica. 2025 Jan 1;110(1):234-238. doi: 10.3324/haematol.2024.285837.
Abstract
摘要
Zotero 插件